Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
10/04/1995 | EP0674655A1 Acyclic peptide analogs of the atrial natriuretic peptide, process for producing the same and their use |
10/04/1995 | EP0674654A1 Acyclic, sulphureous peptides as analogs of the atrial natriuretic peptide |
10/04/1995 | EP0674526A1 Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease |
10/04/1995 | EP0547059B1 Pancreas-elastasis-1-specific antibody, a process for obtaining it and a test kit containing such antibodies |
10/04/1995 | EP0529019B1 Nematode vaccine |
10/04/1995 | EP0347431B1 Expression of proteins in milk |
10/04/1995 | EP0271577B1 Immunomodulating compositions and their use |
10/04/1995 | CN1109505A Interferon-alpha/beta binding protein, its preparation and use |
10/04/1995 | CN1109364A Insulin formulation |
10/03/1995 | US5455338 Anticoagulants; protease inhibitors; thrombosis; surgery |
10/03/1995 | US5455337 Treatment of asthma, helminth infections |
10/03/1995 | US5455331 Enriched whey protein fractions and method for the production thereof |
10/03/1995 | US5455330 Isolated pure protein having specified amino acid sequence |
10/03/1995 | US5455329 DNA sequences coding for PTH variants, PTH variants, expression vector, bacterial host, use and therapeutic composition |
10/03/1995 | US5455231 Having calcium phosphate stably and uniformly distributed with collagen fibrils |
10/03/1995 | US5455228 Peptidase resistant thrombin receptor peptide ligand |
10/03/1995 | US5455227 Biologically active lipoprotein and its use |
10/03/1995 | US5455181 Anticoagulant |
10/03/1995 | US5455179 Quantitative analysis using polypeptide |
10/03/1995 | US5455169 Isolated nucleic acids which code human amyloid precursor protein, for detection and drug screening |
10/03/1995 | US5455167 DNA construct encoding luxD protein in Brassica plant seed from bioluminescent bacterium; genetic engineering to produce C14:0 fatty acids |
10/03/1995 | US5455165 Nucleic acids encoding polypeptides useful as cell surface adhesion molecules; therapy, diagnosis |
10/03/1995 | US5455158 Imaging fibrin-containing substance using labeled polypeptide imaging agent which binds to fibrin |
10/03/1995 | US5455034 Fusobacterium necrophorum leukotoxoid vaccine |
10/03/1995 | US5455031 Polypeptide with 46 Kdalton HMFG differentiation antigen binding specificity, composition, kit and diagnostic method |
10/03/1995 | US5455029 Therapeutic compositions comprising a mixture of human CuZn superoxide dismutase analogs |
10/03/1995 | CA2054517C Recombinant adeno-associated virus vectors |
10/03/1995 | CA1337181C Recombinant herpes simplex gb-gd vaccine |
10/03/1995 | CA1337180C Dna sequence participating in the regulation of the expression of a dna sequence coding for a precursor of a polypeptide, expression vectors and process for the periplasmic production of the polypeptide |
10/01/1995 | CA2145960A1 Protein phbp-70 |
09/28/1995 | WO1995025957A1 HUMAN C5a ANTAGONISTS AND AGONISTS |
09/28/1995 | WO1995025954A1 Method of testing neurotoxicity of poliovirus vaccine |
09/28/1995 | WO1995025813A1 Germline mutations in the mts gene and method for detecting predisposition to cancer at the mts gene |
09/28/1995 | WO1995025809A1 Compacted nucleic acids and their delivery to cells |
09/28/1995 | WO1995025804A1 Recombinant adenoviruses coding for brain-derived neurotrophic factor (bdnf) |
09/28/1995 | WO1995025803A1 RECOMBINANT ADENOVIRUSES CODING FOR ACIDIC FIBROBLAST GROWTH FACTOR (aFGF) |
09/28/1995 | WO1995025802A1 RECOMBINANT ADENOVIRUSES FOR GLIAL MATURATION FACTOR BETA (GMF-β) |
09/28/1995 | WO1995025797A1 POLYPEPTIDES FOR DIAGNOSING INFECTION WITH $i(TRYPANOSOMA CRUZI) |
09/28/1995 | WO1995025796A1 C-terminally truncated cftr genes and proteins |
09/28/1995 | WO1995025795A1 HUMAN trk RECEPTORS AND NEUROTROPHIC FACTOR INHIBITORS |
09/28/1995 | WO1995025793A1 Dyslipoproteinaemia-sensitised transgenic rabbit |
09/28/1995 | WO1995025789A1 Highly efficient production and isolation of viral particles |
09/28/1995 | WO1995025788A1 Novel mutated viruses, anti-viral compounds and novel methods of making vaccines |
09/28/1995 | WO1995025786A1 Production of human apolipoprotein a1 in a bacterial expression system |
09/28/1995 | WO1995025785A1 EXPRESSION PLASMIDS REGULATED BY AN osmB PROMOTER |
09/28/1995 | WO1995025749A2 Eating suppressant peptides |
09/28/1995 | WO1995025748A1 Topical fibrinogen complex |
09/28/1995 | WO1995025747A1 Prostaglandin e receptor |
09/28/1995 | WO1995025746A1 Modified polypeptides with increased biological activity |
09/28/1995 | WO1995025745A1 Fucose containing proteoglycan or acid glycan and their pharmace utical use |
09/28/1995 | WO1995025744A1 Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases |
09/28/1995 | WO1995025743A1 Enhanced secretion of polypeptides |
09/28/1995 | WO1995025742A1 Pasteurellaceae antigens and related vaccines |
09/28/1995 | WO1995025740A1 Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules |
09/28/1995 | WO1995025739A1 Isolated, mage-3 derived peptides which complex with hla-a2 molecules and uses thereof |
09/28/1995 | WO1995025738A1 Recombinase-deficient helicobacter pylori and related methods |
09/28/1995 | WO1995025543A1 Methods and compositions useful for inhibition of angiogenesis |
09/28/1995 | WO1995025541A1 Bovine neospora isolates and their uses |
09/28/1995 | WO1995025539A1 Novel remedy for respiratory-tract viral disease |
09/28/1995 | WO1995025536A1 Methods and compositions for inhibition of hepatic clearance of tissue factor pathway inhibitor |
09/28/1995 | WO1995025535A1 Thyroxin-binding proteins |
09/28/1995 | WO1995025530A1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof |
09/28/1995 | WO1995025429A1 Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence |
09/28/1995 | WO1995023973A3 Hiv immunoassay utilizing recombinant protein and synthetic peptide reagents |
09/28/1995 | WO1995023860A3 KUNITZ DOMAIN INHIBITOR PROTEINS DERIVED FROM ALZHEIMER'S AMYLOID β-PROTEIN PRECURSOR INHIBITOR |
09/28/1995 | WO1995023855A3 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
09/28/1995 | WO1995022612A3 Genes and genetic elements associated with sensitivity to platinum-based drugs |
09/28/1995 | WO1995020666A3 Transgenic non-human mammals with progressive neurologic disease |
09/28/1995 | WO1995016048A3 Recombinant protein production in bovine adenovirus expression vector system |
09/28/1995 | WO1994025597A3 METHODS AND COMPOSITIONS FOR DETECTION OF $i(SALMONELLA) |
09/28/1995 | DE4411588C1 Buffer, contg. betaine, for RNA- and DNA-polymerase reactions |
09/28/1995 | DE19510551A1 Oral insulin prepns resistant to proteolytic enzymes |
09/28/1995 | CA2186235A1 Polypeptides for diagnosing infection with trypanosoma cruzi |
09/28/1995 | CA2186231A1 Prostaglandin e receptor |
09/28/1995 | CA2186121A1 Pasteurellaceae antigens and related vaccines |
09/28/1995 | CA2186111A1 Novel remedy for respiratory-tract viral disease |
09/28/1995 | CA2186035A1 Thyroxin-binding proteins |
09/28/1995 | CA2186006A1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof |
09/28/1995 | CA2186005A1 Isolated, mage-3 derived peptides which complex with hla-a2 molecules and uses thereof |
09/28/1995 | CA2185450A1 Eating suppressant peptides |
09/28/1995 | CA2185343A1 Enhanced secretion of polypeptides |
09/28/1995 | CA2184409A1 Recombinant adenoviruses coding for acidic fibroblast growth factor (afgf) |
09/28/1995 | CA2184408A1 Recombinant adenoviruses for glial maturation factor beta (gmf-.beta.) |
09/28/1995 | CA2184202A1 Dyslipoproteinaemia-sensitised transgenic rabbit |
09/28/1995 | CA2184200A1 Recombinant viruses, preparation and use in genic therapy |
09/28/1995 | CA2162997A1 Topical fibrinogen complex |
09/28/1995 | CA2162147A1 Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence |
09/27/1995 | EP0674178A2 Cyclosporin immunoassay |
09/27/1995 | EP0674176A1 Electrochemiluminescent rhenium moieties and methods of production |
09/27/1995 | EP0674004A1 MSRV1 virus and pathogenic and/or infections agent MSRV2 linked to multiple sclerosis, their nucleic components and their applications |
09/27/1995 | EP0674003A2 Modulatory proteins of human CNS receptors |
09/27/1995 | EP0673948A1 Pepticles derived from a retrovirus of the HIV-group and their use |
09/27/1995 | EP0673440A1 Mammalian muscle nad:arginine adp-ribosyltransferase |
09/27/1995 | EP0673431A1 Gene therapy for cystic fibrosis |
09/27/1995 | EP0673430A1 Nucleotide sequence for treating cancer and infection |
09/27/1995 | EP0673428A1 Identification of compounds modulations protein/cell membrane association |
09/27/1995 | EP0673427A1 Process for immobilizing enzymes to the cell wall of a microbial cell by producing a fusion protein |
09/27/1995 | EP0673425A1 Dna encoding chitin deacetylase |
09/27/1995 | EP0673423A1 Viral resistance by plant transformation with a replicase portion of a plant virus genome |
09/27/1995 | EP0673421A1 Allergenic proteins and peptides from johnson grass pollen |